
Medicamen Organics Limited IPO
- IPO Date21 Jun, 2024 to 25 Jun, 2024
- Listing Date28 Jun, 2024
- Face Value₹10 per share
- Issue Price₹32 to ₹34 per share
- Lot Size4000 Shares
- Minimum Investment₹1,36,000
- Listing AtNSE SME
- Total Issue Size31,00,000 Shares
(aggregating up to ₹10.54 Cr) - Fresh Issue31,00,000 Shares
(aggregating up to ₹10.54 Cr)
- Offer for Sale-
- Issue TypeBook Built Issue IPO
- Share holding pre issue86,00,000
- Shareholding post issue1,17,00,000
IPO Dates
Closing Date
25 Jun, 2024
Initiation of Refunds
27 Jun, 2024
Listing Date
28 Jun, 2024
21 Jun, 2024
Opening Date
26 Jun, 2024
Basis of Allotment
27 Jun, 2024
Credit of Shares
Medicamen Organics Limited Lot Size
Investors can bid for a minimum of 4000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Max) | 1 | 4000 | ₹1,36,000 |
| S-HNI (Max) | - | - | - |
| S-HNI (Min) | 2 | 8000 | ₹2,72,000 |
| Retail (Min) | 1 | 4000 | ₹1,36,000 |
| B-HNI (Min) | - | - | - |
Medicamen Organics Limited Promoter Holding
Mr. Bal Kishan Gupta is the promoter of the company.
| Pre Issue Share Holding | Post Issue Share Holding |
|---|---|
| 81.21% | - |
Medicamen Organics Limited COMPANY INFORMATION
Medicamen Organics IPO is a book built issue of Rs 10.54 crores. The issue is entirely a fresh issue of 31 lakh shares. Medicamen Organics IPO opens for subscription on June 21, 2024 and closes on June 25, 2024. The allotment for the Medicamen Organics IPO is expected to be finalized on Wednesday, June 26, 2024. Medicamen Organics IPO will list on NSE SME with tentative listing date fixed as Friday, June 28, 2024. Medicamen Organics IPO price band is set at ₹32 to ₹34 per share. The minimum lot size for an application is 4000 Shares. The minimum amount of investment required by retail investors is ₹136,000. The minimum lot size investment for HNI is 2 lots (8,000 shares) amounting to ₹272,000. GYR Capital Advisors Private Limited is the book running lead manager of the Medicamen Organics IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Medicamen Organics IPO is Giriraj Stock Broking. Refer to Medicamen Organics IPO RHP for detailed information.
Medicamen Organics Limited was incorporated in 1995 and develops, manufactures, and distributes pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Governments) and private entities as a contract manufacturer/third party manufacturer.
The company's product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company's products are marketed throughout India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
The company has two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering an area of 21,536 Sq. Ft. As on September 30, 2023, the company has entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.
As of September 30, 2023, the company employed a total of 116 people.
FAQs About Medicamen Organics Limited Ipo
Medicamen Organics Limited IPO will open on 21 Jun, 2024 and close on 25 Jun, 2024. Investors must apply within this period to participate.
The Medicamen Organics Limited IPO price band is set between ₹32.00 and ₹34.00 per share. The minimum lot size is 4000, requiring an investment of at least ₹136000.00.
The Medicamen Organics Limited IPO shares are expected to be listed on 28 Jun, 2024, subject to regulatory approvals and final allotment.
You can track your Medicamen Organics Limited IPO application status on the registrar’s website: Link Intime or KFintech using your PAN, application number, or DP ID
The Medicamen Organics Limited IPO will be listed on major stock exchanges such as BSE, where you can trade shares once they are listed.